ArticleBMC complementary medicine and therapies2025
Genotoxicity and acute toxicity of Hyunburikyung-tang: assessing the safety of prescribing traditional Korean medicine for dysmenorrhea.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHyunburikyung-tang exerts an anti-inflammatory effect by suppressing pro-inflammatory cytokines and prostaglandin E2 and is clinically used to improve dysmenorrhea in Korea. It contains various medicinal plants including peach seeds (Prunus persica Batsch) and safflower (Carthamus tinctorius Linn). Peach seeds contain amygdalin, which demonstrates teratogenic effects, and safflower is reported to cause reproductive toxicity and teratogenic effects in mice. These findings raise concerns regarding the teratogenic potential of these substances. A potential correlation exists between genotoxicity and teratogenicity. Genotoxic substances can damage DNA and cause mutations or chromosomal abnormalities, which may result in developmental malformations. Therefore, we aimed to assess whether Hyunburikyung-tang causes acute toxicity or genotoxicity.
methodsSeven-week-old male and female Sprague-Dawley rats were orally administered a single dose of Hyunburikyung-tang to assess acute toxicity (625, 1,250, or 2,500 mg/kg). Body weight measurements, general symptom observations, and autopsy examinations were used to confirm toxic responses according to Toxicity Test Guidelines for Drugs, etc. [No. 2022-18, the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea]. Genotoxicity assessment was conducted with bacteria, cells, and mice, according to the organization for economic cooperation and development test guidelines (TG 471, TG473, and TG474).
resultsRegarding the acute toxicity assessment, oral administration of Hyunburikyung-tang at doses up to 2,500 mg/kg in male and female rats did not result in body weight loss (p > 0.05), and general symptoms including death, weakening, irregular respiration etc. was did not observed. Upon necropsy, no visible damage was observed in major organs such as the liver and heart. Hyunburikyung-tang not only showed no mutagenic activity in the Bacterial reverse mutation test, but also did not significantly increase the incidence of chromosomal aberrations or the frequency of micronuclei in bone marrow (p > 0.05). Moreover, in the in vitro test, no genotoxicity was induced when metabolic activation by rat liver fractions was applied to mimic hepatic metabolism.
conclusionsOur findings suggested that Hyunburikyung-tang does not induce acute toxicity or genotoxicity. Nevertheless, follow-up research should be conducted to confirm toxicity caused by repeated administration and adverse effects on embryonic cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.